Toggle navigation
Home
Search
Services
Blog
Contact
About
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
Search grants from
Share this grant:
:
:
Abstract
Funding
Related projects
Comments
Recent in Grantomics:
Your institution
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Treatment of Muscular Dystrophy by Increased Angiogenesis
Genome-wide association study of breast cancer in high-risk women
Shared Decision Making in Diverse, Disadvantaged Populations;Addressing Health D
Grants for Predoctoral Training in Family Medicine
Forecasts and Forecasting Models: Prediction, Evaluation, Estimation, and Selection Using the Relevant Loss Function
Recently added grants:
Reducing breast cancer risk through modifying body composition and decreasing inflammation in normal weight women
Roles of Neogenin and Matriptase-2 in Iron Homeostasis
Understanding Polycystin-1 Structure-GPCR Function for the Development of New Therapeutic Approaches in ADPKD
Mechanisms of atrazine endocrine disruption
Regulation of Photoreceptor Neurotransmisssion
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Research and Development Contracts (N01)
Project #
N01CN35157-6-0-1
Application #
7575955
Study Section
Project Start
2003-09-30
Project End
2008-09-29
Budget Start
Budget End
Support Year
Fiscal Year
2007
Total Cost
Indirect Cost
Related projects
NIH 2008
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/ Northwestern University at Chicago
$1,704,878
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Cancer Chemopreventive Agents
Bergan, Raymond C. /
$1,602,000
NIH 2007
N01 CA
Phase 1 and Phase 2 Clinical Trials of Agents for Cancer Prevention
/
Comments
Be the first to comment on this grant